| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P6179 | Dimensions Publication ID | 1037096102 |
| P356 | DOI | 10.1186/S13075-014-0435-Y |
| P932 | PMC publication ID | 4207310 |
| P698 | PubMed publication ID | 25253302 |
| P5875 | ResearchGate publication ID | 266151813 |
| P50 | author | Janet Pope | Q48742471 |
| P2093 | author name string | Jason J Lee | |
| P2860 | cites work | Biochemical characterization of ADP-ribose polymer metabolism in SLE. | Q51031046 |
| Probable Inference, the Law of Succession, and Statistical Inference | Q57076228 | ||
| Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study | Q64110556 | ||
| Increased risks of deep vein thrombosis and pulmonary embolism in Sjögren syndrome: a nationwide cohort study | Q64110578 | ||
| Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus | Q81011193 | ||
| Incidence of thromboembolic events in patients with primary Sjögren's syndrome | Q81093887 | ||
| Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study | Q81662754 | ||
| High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients | Q82635832 | ||
| Risk of venous thromboembolism with rheumatoid arthritis | Q83162699 | ||
| Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort | Q87051922 | ||
| Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization | Q87405670 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Venous syndromes and pulmonary embolism in systemic lupus erythematosus | Q33552588 | ||
| Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study | Q33789578 | ||
| Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort | Q33871715 | ||
| Risk of venous thromboembolism in patients with rheumatoid arthritis | Q33877737 | ||
| Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). | Q34169570 | ||
| Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden | Q34236174 | ||
| Platelets in Inflammation and Thrombosis | Q34263823 | ||
| Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations | Q34712199 | ||
| The epidemiology of venous thromboembolism. | Q35157791 | ||
| Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? | Q36327186 | ||
| Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. | Q38159868 | ||
| Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. | Q41109148 | ||
| The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. | Q43488992 | ||
| Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus | Q43507189 | ||
| Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors | Q43807830 | ||
| Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study | Q43846279 | ||
| Venous thromboembolism in patients with dermatomyositis and polymyositis. | Q43912336 | ||
| Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study | Q44326255 | ||
| Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset | Q44729726 | ||
| Skin-antigen specific antibodies are detected in UV irradiation and TLR7 agonist induced lupus-like disease in autoimmune prone NOD mice and in pediatric SLE. | Q46196973 | ||
| Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients | Q46443879 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | inflammation | Q101991 |
| meta-analysis | Q815382 | ||
| venous thromboembolism | Q9397786 | ||
| P304 | page(s) | 435 | |
| P577 | publication date | 2014-09-25 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases | |
| P478 | volume | 16 |
| Q33706485 | Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. |
| Q36956746 | Associations of Trauma Exposure and Posttraumatic Stress Symptoms With Venous Thromboembolism Over 22 Years in Women |
| Q92174371 | Clinical Characteristics of Patients With CRVO in One Eye With Subsequent RVO in The Fellow Eye: A Retrospective Observational Study |
| Q40562190 | Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study |
| Q26771128 | Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? |
| Q98292368 | Extrapulmonary Involvement in Sarcoidosis: A Case Report |
| Q64041611 | Genetics in systemic lupus erythematosus: entering the borough of cardiovascular risk |
| Q90201394 | Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism |
| Q38972344 | Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives. |
| Q52349399 | Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview. |
| Q96028621 | Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research |
| Q38359475 | Postoperative risk of venous thromboembolism in rheumatic disease patients |
| Q58093382 | Prevalence and risk factors of deep venous thrombosis in patients with longitudinally extensive transverse myelitis: one center data from China |
| Q89718029 | Progress in the research on venous thromboembolism |
| Q92712661 | Prophylaxis and Therapy of Venous Thrombotic Events (VTE) in Pregnancy and the Postpartum Period |
| Q38819355 | Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. |
| Q40685241 | Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study |
| Q47671088 | Sex, Symptom Severity, and Quality of Life in Rheumatology |
| Q92667904 | Stratifying management of rheumatic disease for pregnancy and breastfeeding |
| Q40404975 | Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis |
| Q50052795 | The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis. |
| Q38744550 | The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study |
| Q54956023 | The Role of Inflammation in Venous Thromboembolism. |
| Q90458276 | The prophylaxis of venous thromboembolism in medical outpatients: results of a survey among italian general practitioners |
| Q89181533 | The role of neutrophil extracellular traps in rheumatic diseases |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
| Q54123341 | Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk? |
| Q91958762 | Vascular Ultrasound Statement from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology - 2019 |
| Q92501384 | Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy |
Search more.